BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Zinfandel Pharmaceuticals Inc.  



Durham  North Carolina    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Diagnostics






 Company News
Takeda Pharmaceutical Co. Ltd. (TKPYY) and Zinfandel Pharmaceuticals Inc. Initiate Phase 3 TOMMORROW Trial of AD-4833 for the Delay of Onset of Mild Cognitive Impairment Due to Alzheimer's Disease in Subjects Selected Using a Genetic-Based Biomarker Risk Assignment Algorithm 8/26/2013 11:29:50 AM    More...
Takeda and Zinfandel Pharmaceuticals Inc. Announce Results of a Study of the Performance Characteristics of a Genetics-Based Biomarker Risk Assignment Algorithm to Identify Risk of Mild Cognitive Impairment Due to Alzheimer's Disease 7/17/2013 10:15:19 AM    More...
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) and Zinfandel Pharmaceuticals Inc. Sign Licensing Agreement for Alzheimer's Disease Biomarker in Combination with Pioglitazone; Zinfandel to Receive $9M Upfront, Payments of up to $78M 1/11/2011 6:39:41 AM    More...

//-->